(Q22061804)
English
New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine
scientific article
- New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine
Statements
New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine (English)
0 references
New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine (English)
0 references
S Looareesuwan
S. Looareesuwan
Looareesuwan
1 reference
S. Krudsood
1 reference
N. Tangpukdee
1 reference
P. Wilairatana
1 reference
W. Phumratanaprapin
1 reference
W. Leowattana
1 reference
K. Chalermrut
1 reference
S. Ramanathan
1 reference
V. Navaratnam
1 reference
P. Olliaro
1 reference
M. Vaillant
1 reference
J. R. Kiechel
1 reference
W. R. J. Taylor
1 reference
14 June 2010
0 references
September 2010
0 references
54
0 references
9
0 references
3730-3737
0 references
3730-7
0 references
2 references
1 reference